Tekturna
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
70839-150 -
Package NDC
70839-150-30 -
Application number
NDA021985 -
SPL ID
130d24ec-4b3b-0978-e063-6394a90af0c8 -
SPL set ID
3dd61fa5-1620-4ebf-bbdb-ede29b92fce2 -
UNII
C8A0P8G029 -
RxCUI
1011736 -
RxCUI
1011738 -
RxCUI
1011739 -
RxCUI
1011741
What the source publishes
- Labeler
- LXO US Inc.
- Active ingredients
- aliskiren hemifumarate
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Tekturna",
"splId": "130d24ec-4b3b-0978-e063-6394a90af0c8",
"labels": [
{
"setId": "3dd61fa5-1620-4ebf-bbdb-ede29b92fce2",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3dd61fa5-1620-4ebf-bbdb-ede29b92fce2",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3dd61fa5-1620-4ebf-bbdb-ede29b92fce2"
}
],
"routes": [
"ORAL"
],
"labeler": "LXO US Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET, FILM COATED in 1 BOTTLE (70839-150-30)",
"package_ndc": "70839-150-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20170101"
}
],
"productId": "70839-150_130d24ec-4b3b-0978-e063-6394a90af0c8",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "70839-150",
"deaSchedule": null,
"genericName": "aliskiren hemifumarate",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ALISKIREN HEMIFUMARATE",
"strength": "150 mg/1"
}
],
"applicationNumber": "NDA021985",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20070305",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0370839300306"
],
"unii": [
"C8A0P8G029"
],
"rxcui": [
"1011736",
"1011738",
"1011739",
"1011741"
],
"spl_set_id": [
"3dd61fa5-1620-4ebf-bbdb-ede29b92fce2"
],
"manufacturer_name": [
"LXO US Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:70839-150_130d24ec-4b3b-0978-e063-6394a90af0c8"